Nab-Paclitaxel as Possible Option for Relapsed NSCLC

(MedPage Today) -- Patients with previously treated advanced non-small cell lung cancer had similar overall survival (OS) with docetaxel and nab-paclitaxel (Abraxane), but the latter improved progression-free survival (PFS) and was better tolerated...